Back
Full-text
Journal article

EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision.

  • Verberne HJ Department of Nuclear Medicine, F2-238, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. h.j.verberne@amc.uva.nl.
  • Acampa W Institute of Biostructures and Bioimaging, National Council of Research, Naples, Italy.
  • Anagnostopoulos C Center for Experimental Surgery, Clinical and Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece.
  • Ballinger J Department of Nuclear Medicine, Guy's Hospital - Guy's & St Thomas' Trust Foundation, London, UK.
  • Bengel F Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
  • De Bondt P Department of Nuclear Medicine, OLV Hospital, Aalst, Belgium.
  • Buechel RR Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland.
  • Cuocolo A Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.
  • van Eck-Smit BL Department of Nuclear Medicine, F2-238, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Flotats A Nuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Hacker M Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Hindorf C Department of Radiation Physics, Skåne University Hospital, Lund, Sweden.
  • Kaufmann PA Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland.
  • Lindner O Heart and Diabetes Center North Rhine-Westphalia, Institute for Radiology, Nuclear Medicine and Molecular Imaging, University Hospital of the Ruhr-University Bochum, Bad Oeynhausen, Germany.
  • Ljungberg M Department of Medical Radiation Physics, Lund University, Lund, Sweden.
  • Lonsdale M Department of Clinical Physiology and Nuclear Medicine, Bispebjerg Hospital, Copenhagen, Denmark.
  • Manrique A Department of Nuclear Medicine, Service Commun Investigations chez l'Homme, GIP Cyceron, Caen University Hospital, Caen, France.
  • Minarik D Radiation Physics, Skåne University Hospital, Malmö, Sweden.
  • Scholte AJ Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Slart RH Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Trägårdh E Clinical Physiology and Nuclear Medicine, Skåne University Hospital and Lund University, Malmö, Sweden.
  • de Wit TC Department of Nuclear Medicine, F2-238, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Hesse B Department of Clinical Physiology and Nuclear Medicine & PET, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
Show more…
  • 2015-08-21
Published in:
  • European journal of nuclear medicine and molecular imaging. - 2015
Guidelines
Myocardial perfusion imaging
Nuclear medicine
Procedures
Adult
Contrast Media
Coronary Artery Disease
Dose-Response Relationship, Drug
Exercise
Humans
Image Processing, Computer-Assisted
Male
Middle Aged
Multimodal Imaging
Myocardial Perfusion Imaging
Practice Guidelines as Topic
Purines
Pyrazoles
Radiation Exposure
Safety
Societies, Medical
Software
Tomography, X-Ray Computed
Vasodilator Agents
English Since the publication of the European Association of Nuclear Medicine (EANM) procedural guidelines for radionuclide myocardial perfusion imaging (MPI) in 2005, many small and some larger steps of progress have been made, improving MPI procedures. In this paper, the major changes from the updated 2015 procedural guidelines are highlighted, focusing on the important changes related to new instrumentation with improved image information and the possibility to reduce radiation exposure, which is further discussed in relation to the recent developments of new International Commission on Radiological Protection (ICRP) models. Introduction of the selective coronary vasodilator regadenoson and the use of coronary CT-contrast agents for hybrid imaging with SPECT/CT angiography are other important areas for nuclear cardiology that were not included in the previous guidelines. A large number of minor changes have been described in more detail in the fully revised version available at the EANM home page: http://eanm.org/publications/guidelines/2015_07_EANM_FINAL_myocardial_perfusion_guideline.pdf .
Language
  • English
Open access status
hybrid
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/258197
Statistics
Document views: 61 File downloads:
  • Full-text: 0